Infectieziekten

Infectieziekten
1
Schipper HG, Simsek S, van Agtmael MA, van Lienden KP.
Bone hydatid disease refractory to nitazoxanide treatment Am J Trop Med Hyg.
2009;81(3)446-448
2
Peters RP, de Boer RF, Schuurman T, Gierveld S, Kooistra-Smid M, van
Agtmael MA, Vandenbroucke-Grauls CM, Persoons MC, Savelkoul PH.
Streptococcus pneumoniae DNA load in blood as a marker of infection in
patients with community-acquired pneumonia. J Clin Microbiol.
2009;47(10):3308-12:.
3
van den Berg R, van Hoogstraten I, van Agtmael MA. Non-responsiveness to
hepatitis B vaccination in HIV seropositive patients; possible causes and
solutions. AIDS Rev. 2009;11(3):157-64. Review
4
Nijhuis M, Wensing AM, Bierman WF, de Jong D, Kogan R, Fau A, Jaspers CA,
Schurink KA, van Agtmael MA, Boucher CA.
Failure of treatment with first-line lopinavir boosted with ritonavir can be
explained by novel resistance pathways with protease mutation 76V.
J Infect Dis. 2009;200(5):698-709.
5
van Vonderen MG, van Agtmael MA, Hassink EA, Milinkovic A, Brinkman K,
Geerlings SE, Ristola M, van Eeden A, Danner SA, Reiss P; MEDICLAS study
group. Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.
PLoS One. 2009;21;4(5):5647.
6
van Vonderen MG, Hassink EA, van Agtmael MA, Stehouwer CD, Danner SA,
Reiss P, Smulders Y Increase in carotid artery intima-media thickness and
arterial stiffness but improvement in several markers of endothelial function after
irritation of antiretroviral therapy. J Infect Dis. 2009;199(8):1186-94.
7
Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA HIV
monotherapy with ritonavir-boosted protease inhibitors: a systematic review.
AIDS. 2009;23(3):279-91.
8
Peters R.P.H., Savelkoul P.H.M., Vandenbroucke-Grauls C.M.J.E, van Agtmael
M.A., Simoons-Smit A.M. Rapid detection of microbial infection in the ICU: An
ongoing search for new diagnostic tools. Netherlands Journal of Critical Care
2009; 13(1):23-30
9
Bomers M , Van Agtmael M. Vaginal douche increases risk of STDs
Nederlands Tijdschrift voor Geneeskunde 2009;153(13):629
M.G.A. van Vonderen, Y.M. Smulders, C.D.A. Stehouwer, S.A. Danner, C.M.
Gundy, F. Vos, P. Reiss, M.A. van Agtmael. Carotid intima-media thickness and
10
arterial stiffness in HIV infected patients: the role of HIV, antiretroviral therapy
and lipodystrophy. Journal of AIDS 2009;50:53-61
1
Vasculaire geneeskunde
Van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M,
Stehouwer CD, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM,
11 Smulders YM, Dijkmans BA, Nurmohamed MT. Rheumatoid arthritis versus
diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the
CARRE investigation. Ann Rheum Dis. 2009;68(9):1509-1510
Peters MJ, van Eijk IC, Smulders YM, Serne E, Dijkmans BA, van der HorstBruinsma IE, Nurmohamed MT. Signs of Accelerated Preclinical
12
Atherosclerosis in Patients with Ankylosing Spondylitis. J Rheumatol. 2009;Dec
1. Epub ahead of print
Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK,
13 Micinnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb AG,
Sidiropoulos P, Kitas G
Smulders Y.M., Sobrier MJ, Szekanecz Z, Sattar NG, Nurmohamed MT.
EULAR evidence-baced recommendations for cardiovascular risk management
14
in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann
Rheum Dis. 2009;sep 22. Epub ahead of print.
Verweij JW, Hofstee HMA, Golding RP, Waesberghe JHTM van, Smulders YM.
Interobserver agreement between on-call radiology residents and radiology
15 specialists in the diagnosis of pulmonary embolism using CT pulmonary
angiography. Journal of Computer Assisted Tomography Decision 2009;33:952955.
Hofstee HMA, Vonk Noordegraaf A, Voskuyl AE, Dijkmans PE, Postmus PE,
Smulders YM, Serné EH.Nailfold capillary density is associated with the
17
presence and severity of pulmonary arterial hypertension in systemic sclerosis.
Annals of Rheumatic Diseases 2009;68:191-195.
Hofstee HMA, Voskuyl AE, Serné EH, Smulders YM. Het fenomeen van
18 Raynaud – Stand van zaken. Nederlands Tijdschrift voor Geneeskunde
2009;53:1074-1081.
Kooter AJ, Smulders YM.
19 Aldosteronblokkade bij proteinurie: een ondergewaardeerde behandeling.
Ned Tijdschr Geneesk 2009;153:710-14
2
20
21
22
23
Nanayakkara PWB, Le Poole CY, Fouque D, van Guldener C, Stehouwer
CD, Smulders YM, van Ittersum F. Adiponectin concentration has an inverse
and a non linear associaton with estimated glomerular filtration rate in
patients with K/DOQI 3 – 5 chronic kidney disease.Clin Nephrol 2009;72:2130
Nanayakkara PWB, Kiefte-deJong JC, ter Wee PM et al. A treatment
strategy consisting of pravastatin, vitamin E and homocysteine lowering does
not lower plasma asymmetric dimethylarginine (ADMA) concentration in
patients with mild to moderate kidney disease: a randomized, double-blind,
placebocontrolled trial. Am J Kid Dis 2009;53:41-50
Hu H, Meijer OG, van Dieen JH, Hodges PW, Bruijn SM, Strijers RL,
Nanayakkara PWB et al. Muscle activity during the active straight leg raise
(ASLR), and the effects of a pelvic belt on the ASLR and on treadmill
walking. J Biomech 2009;nov 1 Epub
Nurmohamed MT. Newer biological agents in the treatment of rheumatoid
arthritis: do the benefits outweigh the risks? Drugs 2009;69(15):2035-43.
Steen KS, Lems WF, Visman IM, de Koning MH, van de Stadt RJ, Twisk JW,
de Leest HT, Dijkmans BA, Nurmohamed MT. The effect of Helicobacter
24
pylori eradication on C-reactive protein and the lipid profile in patients with
rheumatoid arthritis using chronic NSAIDs. Clin Exp Rheumatol. 2009;27:170
Raterman HG, Voskuyl AE, Dijkmans BA, Nurmohamed MT. Use of
25 methotrexate therapy is not associated with decreased prevalence of
metabolic syndrome. Arthritis Res Ther. 2009;11(5):413; author reply 414
Ettema HB, Mulder MC, Nurmohamed MT, Büller HR, Verheyen CC. Dutch
26 orthopedicthromboprophylaxis: a 5-year follow-up survey. Acta Orthop.
2009;80(1):109-12.
Hoving JL, Bartelds GM, Sluiter JK, Sadiraj K, Groot I, Lems WF, Dijkmans
BA, Wijbrandts CA, Tak PP, Nurmohamed MT, Voskuyl AE, Frings-Dresen
MH. Perceived work ability, quality of life, and fatigue in patients with
27
rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective
intervention study and partial economic evaluation. Scand J Rheumatol.
2009;38:246-50
de Vries MK, van der Horst-Bruinsma IE, Nurmohamed MT, Aarden LA,
Stapel SO, Peters MJ, van Denderen JC, Dijkmans BA, Wolbink GJ.
28
Immunogenicity does not influence treatment with etanercept in patients with
ankylosing spondylitis. Ann Rheum Dis. 2009;68(4):531-5
Bos WH, Bartelds GM, Vis M, van der Horst AR, Wolbink GJ, van de Stadt
RJ, van Schaardenburg D, Dijkmans BA, Lems WF, Nurmohamed MT,
29 Aarden L, Hamann D. Preferential decrease in IgG4 anti-citrullinated protein
antibodies during treatment with tumour necrosis factor blocking agents in
patients with rheumatoidarthritis. Ann Rheum Dis. 2009;68(4):558-63
3
30
Nurmohamed MT, Dijkmans BA. Dyslipidaemia, statins and rheumatoid
arthritis. Ann Rheum Dis. 2009;68(4):453-5
Peters MJ, Visman I, Nielen MM, van Dillen N, Verheij RA, van der HorstBruinsma IE, Dijkmans BA, Nurmohamed MT. Ankylosing spondylitis; a risk
31
factor for myocardial infarction? Ann Rheum Dis. 2009;Apr 28 Epub ahead of
print
Van Eijk IC, de Vries MK, Levels JH, Peters MJ, Huizer EE, Dijkmans BA,
van der Horst-Bruinsma IE, Hazenberg BP, van de Stadt RJ, Wolbink GJ,
Nurmohamed MT. Improvement of lipid profile is accompanied by
32
atheroprotective alterations in high-density lipoprotein composition upon
tumor necrosis factor blockade: a prospective cohort study in ankylosing
spondylitis. Arthritis Rheum. 2009;60(5):1324-30
Raterman HG, Simsek S, Lems WF, Meesters EW, Dijkmans BA,
33 Nurmohamed MT. Rituximab and thyroid function. Arch Intern Med.
2009;169(11):1073-4
34
Nurmohamed MT. Cardiovascular risk in rheumatoid arthritis. Autoimmun
Rev. 2009;8(8):663-7
Peters MJ, Nurmohamed MT, van Eijk IC, Verkleij CJ, Marx PF.Thrombin35 activatable fibrinolysis inhibitor and its relation with inflammation
inrheumatoid arthritis. Ann Rheum Dis. 2009 Jul;68(7):1232-3
Peters MJ, Watt PH, Cherry L, Welsh P, Henninger E, Dijkmans BA,
McInnes IB, Nurmohamed MT, Sattar N. Lack of effect of TNF{alpha}
36 blockade therapy on circulating adiponectin levels in patients with
autoimmune disease: results from two independent prospective studies. Ann
Rheum Dis. 2009 Jul 28. Epub ahead of print
Bartelds GM, Wijbrandts CA, Nurmohamed MT, Wolbink GJ, de Vries N,
Tak PP, Dijkmans BA, Crusius JB, van der Horst-Bruinsma IE. Anti37
adalimumab antibodies in rheumatoid arthritis patients are associated with
interleukin-10 gene polymorphisms. Arthritis Rheum. 2009;60(8):2541-2
van den Bemt BJ, Vos K, den Broeder AA, Blom M, Thurlings RM, Bartelds
GM, Stapel SO, Barrera P, Tak PP, Nurmohamed MT, Wolbink GJ. A single
38
course of rituximab does not abrogate anti-infliximab antibodies in patients
with rheumatoid arthritis. Ann Rheum Dis. 2009;68(8):1368-9
Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel SO, Lems WF,
Aarden L, Dijkmans BA, Tak PP, Wolbink GJ. Anti-infliximab and anti39 adalimumab antibodies in relation to response to adalimumab in infliximab
switchers and anti-TNF naive patients: a cohort study. Ann Rheum Dis.
2009;60:2541-2542
4
Peters MJ, Nielen MM, Raterman HG, Verheij RA, Schellevis FG,
Nurmohamed MT. Increased cardiovascular disease in patients with
40
inflammatory arthritis in primary care: a cross-sectional observation. J
Rheumatol. 2009;36(9):1866-8
van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M,
Stehouwer CD, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM,
41 Smulders YM, Dijkmans BA, Nurmohamed MT. Rheumatoid arthritis versus
diabetes as a risk factor for cardiovascular disease: a cross-sectional study,
the CARRE Investigation. Ann Rheum Dis. 2009;68(9):1395-1400
Steen KS, Lems WF, Visman IM, Heierman M, Dijkmans BA, Twisk JW,
42 Boers M, Nurmohamed MT. High incidence of cardiovascular events in
patients with rheumatoid arthritis. Ann Rheum Dis. 2009;68(9):1509-1510
van Weely SF, van Denderen CJ, van der Horst-Bruinsma IE, Nurmohamed
MT, Dijkmans BA, Dekker J, Steultjens MP. Reproducibility of performance
43
measures of physical function based on the BASFI, in ankylosing spondylitis.
Rheumatology(Oxford). 2009;48(10):1254-60
de Vries MK, Brouwer E, van der Horst-Bruinsma IE, Spoorenberg A, van
DenderenJC, Jamnitski A, Nurmohamed MT, Dijkmans BA, Aarden LA,
44 Wolbink GJ. Decreased clinical response to adalimumab in ankylosing
spondylitis is associated with antibody formation. Ann Rheum Dis.
2009;68(11):1787-1788
de Vries MK, van Eijk IC, van der Horst-Bruinsma IE, Peters MJ,
Nurmohamed MT, Dijkmans BA, Hazenberg BP, Wolbink GJ. Erythrocyte
45 sedimentation rate, C-reactive protein level, and serum amyloid a protein for
patient selection and monitoring of anti-tumor necrosis factor treatment in
ankylosing spondylitis. Arthritis Rheum. 2009;61(11):1484-90
Dik VK, Peters MJL, Dijkmans PA, van der Weijden MAC, de Vries MK,
Dijkmans BAC, van der Horst-Bruinsma, Nurmohamed MT. The relationship
46 between disease-related characteristics and conduction disturbances in
ankylosing spondylitis. Scandinavian Journal of Rheumatology 2009 Sept 28.
Epub ahead of print
Peters MJ, Welsh P, McInnes IB, Wolbink GJ, Dijkmans BA, Sattar N,
Nurmohamed MT. TNF{alpha} blockade therapy reduces circulating NT47
proBNP levels in RA patients with active disease: results from prospective
cohort study. Ann Rheum Dis. 2009 Nov 27. Epub ahead of print
Peters MJ, Nurmohamed MT, Kitas GD, Sattar N. Statin treatment of
48 rheumatoid arthritis: Comment on the editorial by Ridker and Solomon.
Arthritis Rheum. 2009;62(1):302-303.
5
Nurmohamed MT. Dyslipidemie, inflammatie en reumatoide artritis: geen
49 noodzaak om tocilizumab van andere biologicals te onderscheiden. Ned
Tijdschr Reum 2009;3:39-42
50
Nurmohamed MT. Cardiovasculair risicomanagement bij reumatoide artritis.
Patient Care November 2009:31-35
51 Burger JPW, Serné EH, Nolte F, Smulders YM. Blood pressure response to
moderate physical activity is increased in obesity. Neth J Med 2009;67:342346.
Ketel IJG, Stehouwer CDA, Serné EH, Poel DM, Groot L, Kager C, Hompes
52 PGA, Homburg R, Twisk JW, Smulders YM and Lambalk CB. Microvascular
function has no menstrual-cycle-dependent variation in healthy ovulatory
women. Microcirculation 2009;16:714-724.
van Eijk IC, Peters MJL, Serné EH, van der Horst-Bruinsma I, Dijkmans
BAC, Smulders YM, Nurmohamed MT. Microvascular function is impaired
53
in ankylosing spondylitis and improves after tumour necrosis factor a
blockade. Ann Rheum Dis 2009;68:362-366 .
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H,
Baanstra D, Schnee J, Goldhaber SZ; Dabigatran versus warfarin in the
54
treatment of acute venous thromboembolism. RE-COVER Study Group. N
Engl J Med. 2009;361(24):2342-2352.
Zondag W, Klok FA, Nijkeuter M, Kruip M, Douma RA, Kramer MHH,
Huisman MV; Comparison of risk profile and clinical outcome of patients after
55 acute pulmonary embolism in university and non-university hospitalson
behalf of Christopher study investigators. J Thromb Haemost. 2009 Nov 13.
Epub ahead of print
Djurabi RK, Klok FA, Nijkeuter M, Kaasjager K, Kamphuisen PW, Kramer
MHH,
Kruip MJHA, Leebeek FWG, Buller HR and Huisman MV, Comparison of the
56
clinical usefulness of two quantitative D-Dimer tests in patients with a low
clinical probability of Pulmonary Embolism. Thrombosis Research
2009;123:771-774
Nijkeuter M, Tick LW, Sohne M, Kruip MJHA, Buller HR, Leebeek FWG,
Kramer MHH, Klok FA, Prins MH and Huisman MV. Excluding pulmonary
57
embolism without imaging tests - Can our diagnostic algorithm be optimized?
Thrombosis and Haemostasis 2008;100:1203-1206.
6
Diabetes
De Jong HWAM, Rijzewijk LJ, Lubberink M, Van der Meer RW, Lamb HJ,
Smit JWA, Diamant M, Lammertsma AA. Kinetc models for analysing
58
myocardial [11C]-palmitate data. Eur J Nucl Med Molec Imaging
2009;36:966-78
Bunck MC, Diamant M, Cornér A, Eliasson B, Malloy JL, Shaginian RM,
Deng W, Taskinen M-R, Smith U, Yki-Järvinen H, Heine RJ. One-year
59 treatment with exenatide improves beta-cell function, glycemic control, and
body weight, compared to insulin glargine in metformin treated type 2
diabetes patients. Diabetes Care 2009;32:762-768
Van Raalte D, Ouwens DM, Diamant M. Novel insights into glucocorticoid60 medidated diabetogenic effects: towards expansion of therapeutic options?
Eur J Clin Invest 2009;39:81-93
Van der Meer RW, Rijzewijk LJ, De Jong HWAM, Lamb HJ, Lubberink M,
Romijn JA, Bax JJ, De Roos A, Kamp O, Paulus WJ, Heine RJ,
Lammertsma AA, Smit JWA, Diamant M. Pioglitazone improves cardiac
61
function and alters myocardial substrate metabolism without affecting cardiac
lipid accumulation and high-energy phosphate metabolism in patients with
well-controlled type 2 diabetes mellitus. Circulation 2009;119:2069-2077
Rijzewijk LJ, Van der Meer RW, Lamb HJ, De Jong HWAM, Lubberink M,
Romijn JA, Bax JJ, De Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit
62 JWA, Diamant M. Altered myocardial substrate metabolism and decreased
diastolic function in non-ischemic human diabetic cardiomyopathy: Studies
with cardiac PET and MRI. J Am Coll Cardiol 2009;54:1524-1532
Bunck MC, Giltay EJ, Diamant M, Gooren LJ, Teerlink T. Differential effects
of cross-sex hormonal treatment on plasma asymmetric dimethylarginine
63
(ADMA) in healthy male-to-female and female-to-male transsexuals.
Atherosclerosis 2009;206:245-50
Van Duinkerken E, Klein M, Schoonenboom N, Hoogma R, Moll A, Snoek FJ,
Stam CJ, Diamant M. Functional Brain Connectivity and Neurocognitive
64 Functioning in Patients with Longstanding Type 1 Diabetes Mellitus with and
without Microvascular Complications: a Magnetoencephalography Study.
Diabetes 2009;58:2335-2343
van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BA, Boers M, Voskuyl AE,
Diamant M, Wolbink GJ, Nieuwland R, Nurmohamed MT. Circulating
65 microparticles remain associated with complement activation despite
intensive anti-inflammatory therapy in early rheumatoid arthritis Ann Rheum
Dis 2009;Nov 16 (Epub ahead of print)
7
van Vliet M, von Rosenstiel IA, Schindhelm RK, Brandjes DP, Beijnen JH,
Diamant M. Identifying the metabolic syndrome in obese children and
66
adolescents: do age and definition matter? Curr Clin Pharmacol
2009;4(3):233-238
van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S,
Lubberink M, . Molthoff CFM, Lammertsma AA, van der Velden J, Boer C,
Ouwens DM, Diamant M. Altered myocardial substrate metabolism is
67
associated with myocardial dysfunction in early diabetic cardiomyopathy
in rats: studies using positron emission tomography. Cardiovascular
Diabetology 2009;8(1):39
't Hart, LM, Simonis-Bik AM, Nijpels G, van Haeften TW, Schäfer SA, Jeanine
J. Houwing-Duistermaat JJ, Boomsma DI, Groenewoud MJ, Reiling E, van
Hove EC, Diamant M, Kramer MHH, Heine RJ, Maassen JA, Kirchhoff K,
Machicao F, Häring H-U, Slagboom PE, Willemsen G, Eekhoff EM, de Geus
68
EJ, Dekker JM, Fritsche A. A Combined Risk Allele Score of Eight Type 2
Diabetes Genes Is Associated With Reduced First Phase Glucose Stimulated
Insulin Secretion During Hyperglycemic Clamps. Diabetes 2009;Oc 6 (Epub
ahead of print)
Simonis-Bik AM, Nijpels G, van Haeften TW, Groenewoud MJ, HouwingDuistermaat JJ, Boomsma DI, Reiling E, van Hove EC, Diamant M, Kramer
MHH, Heine RJ, Maassen JA, Slagboom PE, Willemsen G, Eekhoff EM,
69 Dekker JM, de Geus EJ, ‘t Hart LM. Gene variants in the novel type 2
diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A and MTNR1B
affect different aspects of pancreatic beta cell function. Diabetes 2009Oct 15
Epub ahead of print
Ng ACT, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Shanks M,
Nucifora G, Smit JWA, Diamant M, Romijn JA, de Roos A, Leung DY, Lamb
70 HJ, Bax JJ. Findings from Left Ventricular Strain and Strain Rate Imaging in
Asymptomatic Patients with Type 2 Diabetes Mellitus Am J Cardiol
2009;104:1398-1401
Jonker JT, Lamb HJ, van der Meer RW, Rijzewijk LJ, Menting LJ, Diamant
M, de Roos A, Romijn JA, Smit JWA. Pioglitazone compared with metformin
71
increases pericardial fat volume in patients with type 2 diabetes mellitus. J
Clin Endocrinol Metab 2009;Nov 13 Epub ahead of print
Alssema M, El-Harchaoui K, Schindhelm RK, Diamant M, Nijpels G,
Kostense PJ, Teerlink T, Heine RJ, Dallinga-Thie GM, Kuivenhoven JA,
Dekker JM, Scheffer PG. Fasting cholesteryl ester transfer protein
72
concentration is independently associated with the postprandial decrease in
high-density lipoprotein cholesterol concentration after fat-rich meals: the
Hoorn prandial study. Metabolism 2009 Dec 18. Epub ahead of print
8
Van Genugten RE, van Raalte DH, Diamant M. Does GLP-1 receptor
73 agonist therapy add value in the treatment of type 2 diabetes: Focus on
esxenatide. Diabetes Res Clin Pract 2009;86(suppl 1):S26-S34
Bunck M, Debono M, Giltay E, Verheijen AT, Diamant M, Gooren LJ.
74 Autonomous prolactin secretion in 2 male-to-female transgender patients
using conventional oestrogen dosages. BMJ Case Reports 2009;10.1136
Van Vliet M, Diamant M, Van der Lei HDW, Budde H, Von Rosenstiel IA. Het
metabool syndroom bij kinderen met overgewicht en obesitas in Amsterdam75
West: welke definitie identificeert kinderen met een hoog risico Ned Tijdschr
Kindergeneeskd 2009;77:2-10
Hammer S, Van der Meer RW, Lamb HJ, Rijzewijk LJ, Diamant M, De Roos
76 A, Romijn JA, Smit JW. Triglyceriden stapeling in het hart van patiënten met
diabetes mellitus. Ned Tijdschr Diabetologie 2009;7(1):23-29
77
Schindhelm RK, Diamant M, Bilo HJG, Slingerland RJ. 1,5-anhydroglucitol
(1,5AG) en glykemische instelling. Ned Tijdschr Diabetologie 2009;7:43-48
Diamant M, Snoek FJ. Het diabetesonderzoek in het diabetescentrum van
78 het VU medisch centrum Amsterdam: van pathofysiologie naar integrale
zorg. Ned Tijdsch Diabetologie 2009;7:159-62
79
Diamant M. Desarrollo clínico de exenatida (Clinical development of
Exenatide). Biodrugs 2009:23(1):37-43
Oostdam N, van Poppel MN, Eekhoff EM, Wouters MG, van Mechelen W.
Design of FitFor2 study: the effects of an exercise program on insulin
80
sensitivity and plasma glucose levels in pregnant women at high risk for
gestational diabetes. BMC Pregnancy Childbirth 2009;5(9):1.
Simonis-Bik AM, Eekhoff EM, de Moor MH, Kramer MH, Boomsma DI,
Heine RJ, Dekker JM, Maassen JA, 't Hart LM, Diamant M, de Geus EJ.
81
Genetic influences on the insulin response of the beta cell to different
secretagogues. Diabetologia. 2009;12:2570-7.
Rijkelijkhuizen JM, Girman CJ, Mari A, Alssema M, Rhodes T, Nijpels G,
Kostense PJ, Stein PP, Eekhoff EM, Heine RJ, Dekker JM. Classical and
82 model-based estimates of beta-cell function during a mixed meal vs an
OGTT in a population-based cohort. Diabetes Res Clin Pract 2009;83:280288.
Kramer MHH
83 Acetylsalicylic acid does not prevent cardiovascular diseases in diabetic
patients.. Ned Tijdschr Geneeskd. 2009;153(7)291.
9
Endocrinologie
De Graaff LCG, Argente J, Veenma DC, Herrebout MA, Friesema EC,
Uitterlinden AG, Drent ML, Campos-Barros Á, Hokken-Koelega ACS.
84
Genetic screening of a Dutch population with isolated GH deficiency (IGHD).
Clinical Endocrinology 2009; 70:742-750.
Jakobsdóttir S, Twisk JWR, Drent ML. The impact of blood glucose levels on
85 stimulated ACTH and growth hormone release in healthy subjects. Clinical
Endocrinology 2009; 71:853-859.
De Ronde W. Hyperandrogenism after transfer of topical testosterone gel;
86 case report and review of published and unpublished studies. Hum Reprod
2009;24:425-428.
87
De Ronde.W. Testosterone gel for the treatment of male hypogonadism.
Expert Opin Biol Ther 2009;9:249-253.
De Ronde W. J. ten Kulve, J. Woerdeman, F.H. de Jong.. Effects of
88 oestradiol on gonadotropin levels in normal and castrated men. Clin
Endocrinol 2009;71:874-879.
De Ronde W, de Haan A, M.L. Drent. Quality of Life is reduced in patients
89 with Klinefelter syndrome on androgen replacement therapy” Eur J
Endocrinol 2009;160:465-468.
Joshi JD, van Schoor NM, de Ronde W, Schaap LA, Comijs HC, Beekman
AT, . Lips P.. Llow free testosterone levels are associated with prevalence
90
and incidence of depressive symptoms in older men. Clinical Endocrinol
2009;161(4):232-240
de Lange TE, Simsek S, Kramer MHH, Nanayakkara PWB. A case of
cocaine-induced panhypopituitarism with human neutrophil elastase-specific
91
anti-neutrophil cytoplasmic antibodies. European Journal of
Endocrinology2009;160:: 499-502.
Heijboer AC, Netelenbos JC, Blankenstein MA. Meningioma in untreated
92 congenital adrenal hyperplasia: a relationschip? J Neurooncol.
2009;92(2):223-5. Epub 2008 Nov 28.
10
Botstofwisseling
93
Boele van Hensbroek P, van Dijk N, van Breda GF, Scheffer AC, van der
Cammen TJ, Lips P, Goslings JC, de Rooij SE; Combined Amsterdam and
Rotterdam Evaluation of Falls (Carefall) study group. The Carefall triage
instrument identifying risk factors for recurrent falls in elderly patients. Am J
Emerg Med 2009;27:23-36.
94
Pluijm SMF, Steyerberg E, Kuchuk N, Rivadeneira F, Looman C, Van
Schoor N, Koes B, Mackenbach J, Lips P, Pols H. Practical
operationalizations of risk factors for fracture in older women: results from
two longitudinal studies. J Bone Miner Res 2009;24:534-42.
95
Pluijm SM, Koes B, de Laet C, van Schoor NM, Kuchuk NO, Rivadeneira F,
Mackenbach JP, Lips P, Pols HA, Steyerberg EW. A simple risk score for
the assessment of absolute fracture risk in general practice based on two
longitudinal studies. J Bone Miner Res 2009;24:768-74.
96
Lo Galbo AM, de Bree R, Lips P, Leemans CR. Detecting hypothyroidism
after treatment for laryngeal or hypopharyngeal carcinomas: a nationwide
survey in the Netherlands. Eur Arch Otorhinolaryngol 2009;266:713-718.
97
Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman C,
Lips P. Higher levels of 25-hydroxyvitamin D are associated with a lower
incidence of multiple sclerosis only in women. Mult Scler 2009;15:9-15.
98
Van Dijk CE, de Boer MR, Koppes LL, Roos JC, Lips P, Twisk JW. Positive
association between the course of vitamin D intake and bone mineral
density at 36 years in men. Bone 2009;44:437-441.
99
Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P. Vitamin D
status, parathyroid function, bone turnover, and BMD in postmenopausal
women with osteoporosis: global perspective. J Bone Miner Res
2009;24:693-701.
Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P.
Relationships of serum 25-hydroxyvitamin D to bone mineral density and
100
serum parathyroid hormone and markers of bone turnover in older persons.
J Clin Endocrinol Metab 2009;94:1244-1250.
Buizert PJ, van Schoor NM, Lips P, Deeg DJ, Eekhoff EM. Lipid levels: a
101 link between cardiovascular disease and osteoporosis? J Bone Miner Res
2009;24:1103-1109.
Pye SR, Tobias J, Silman AJ, Reeve J, O’Neill TW;EPOS study group.
Childhood fractures do not predict future fractures: results from the
102
European Prospective Osteoporosis Study. J Bone Miner Res
2009;24:1314-1318.
11
Van Vonderen MG, Lips P, van Agtmael MA, Hassink EA, Brinkman K,
Geerlings SE, Sutinen J, Ristola M, Danner SA, Reiss P. First line
103
zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss
compared to nevirapine/lopinavir/ritonavir. Aids 2009;23:1367-1376.
Schoorlemmer RM, Peeters GM, van Schoor NM, Lips P. Relationships
104 between cortisol level, mortality and chronic diseases in older persons. Clin
Endocrinol 2009;71:779-786.
Van Schoor NM, Yu H, Bobula J, Lips P. Cross-geographic region
105 differences in quality of life in women with and without vertebral fracture.
Osteoporosis Int 2009;20:1759-1766.
Stolk L, Zhai G, van Meurs JB, Verbiest MM, Visser JA, Lips P, et al.
106 Uitterlinden AG. Loci at chromosomes 13, 19 and 20 influence age at
natural menopause. Nat Genet 2009;41:645-647
Mithal A, Wahl DA, Bonjour AP, Burckhardt P, Dawson-Hughes B, Lips P,
et al. on behalf of the IOF Committee of Scientific Advisors (CSA) Nutrition
107
Working Group. Global vitamin D status and determinants of
hypovitaminosis D. Osteoporosis Int 2009;20:1807-20.
Heijboer AC, Levitus M, Vervloet MG, Lips P, Wee PM, Dijstelbloem HM,
108 Blankenstein MA. Determination of fibroplast growth factor 23. Ann Clin
Biochem 2009;46:338-40.
Estrada K, Krawczak M, Schreiber S, van Duijn K, Stolk L, van Meurs JB,
Lips P, Kayser M. A genome-wide association study of northwestern
109
Europeans involves the CNP signaling pathway in the etiology of human
height variation. Hum Mol Genet 2009;18:3516-24.
Ursum J, Britsemmer K, van Schaardenburg D, Lips P, Dijkmans BA, Lems
110 W. High prevalence of vertebral deformities in elderly patients with early
rheumatoid arthritis. Ann Rheum Dis 2009;68:1512-3.
Lips P, Bouillon R, van Schoor NM, Vanderschueren D, Verschueren S,
Kuchuk N, Milisen K, Boonen S. Reducing fracture risk with calcium and
vitamin D. Clin Endocrinol 2009;Sept 10
Peeters GM, van Schoor NM, Pluijm SM, Deeg DJ, Lips P. Is there a U111 shaped association between physical activity and falling in older persons?
Osteoporosis Int 2010;21(7):1189-1195
Jakobsdottir S, van Nieuwpoort C, Schaap LA, van Schoor NM, Lips P,
112 Drent M. Serum insulin-like growth factor-1 and body composition in
community dwelling older people. Clin Endocrinol 2010;73(2):173-180
Peeters G, van Schoor NM, Lips P. Fall risk: the clinical relevance of falls
113 and how to integrate fall risk with fracture risk. Best Pract Res Clin
Rheumatol 2009;23:797-804.
12
Hooven FH, Adachi JD, Adami S, Boonen S, Compston J, Cooper C,
Delmas P, Diez-Perez A, Gehlbach S, Greenspan SL, LaCroix A, Lindsay
R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P,
114
Silverman S, Siris E, Watts NB, Anderson FA Jr. The global longitudinal
study of osteoporosis in women (GLOW):rationale and study design.
Osteoporos Int. 2009 Jul;20(7):1107-16. Epub 2009 May 26.
Netelenbos JC, Lems WF, Geusens PP, Verhaar HJ, Boermans AJ,
Boomsma MM, Mulder PG, Papapoulos SE. Spine radiographs to improve
115
the identification of women at high risk for fractures. Osteoporos Int. 2009
20(8):1347-52. Epub 2008 Nov 28.
13
Geriatrie
Wattjes MP, Henneman WJ, van der Flier WM, de Vries O, Träber F,
Geurts JJ, Scheltens P, Vrenken H, Barkhof F. Diagnostic imaging of
116
patients in a memory clinic comparison of MR imaging and 64-detector row
CT. Radiology 2009;253:174-183
14
Algemeen
Heyning FH, Hogendoorn PC, Kramer MHH, Holland CT, Dreef E, Jansen
PMJ
117 Primary lymphoma of bone: extranodal lymphoma with favourable survival
independent of germinal centre, post-germinal centre or indeterminate
phenotype. Clin Pathol. 2009;62(9):820-824.
Timmer-de Mik L, Kardaun SH, Kramer MHH, Hayes DP, Bousema MT
118 Imatinib-induced pseudoporphyria.. Clin Exp Dermatol. 2009;34(6):705-707.
.
119
Van der Veldt AA, Kleijn SA, Nanayakkara PWB. Silicone breast implants
and anaplastic large T-cell lymphoma. JAMA 2009;301:1227
Westland GJ, Nanayakkara PWB, Kramer MHH, Smulders YM.
120 Diagnositc second opinions: What does it add? Patient satisfaction, but
diagnosis is rarely altered. Ned Tijdschr Geneeskd 2009;153: A777.
Zwaan L, Thijs A, Wagner C, Wal G van der, Timmermans DR. Design of a
study on suboptimal cognitive acts in the diagnostic process, the effect on
121
patient outcomes and the influence of workload, fatigue and experience of
physicians. BMC Health Serv Res. 2009;9:65.
Smit D, Cock CC de, Thijs A, Smulders Y. Effects of breath-holding
122 position on the QRS amplitudes in the routine electrocardiogram. J
Electrocardiol. 2009;42(5):400-404
15
1
2
Boekbijdragen
Nurmohamed MT. EULAR Online Course on Rheumatic Diseases, Module
27: Systemic consequences of inflammation: i) Atherosclerosis and
rheumatoid arthritis, ii) Atherosclerosis and spondylarthropathy update 2009
Hachulla E, Beyne-Rauzy O, Soubrier M, Nurmohamed MT. Systemic
consequences of the inflammatory process. In: Bijlsma JWJ, Burmeister
GR, da Silva JAP, Faarvang, KL, Hachulla E, Mariette, eds. Eular
Compendium on Rheumatic Diseases, London, BMJ Group 2009:388-407
16
Proefschriften:
1
11 maart 2009:
Marit van Vonderen
Strategies to limit the metabolic complications of treatment for HIV infection
Promotoren: prof.dr. S.A. Danner; prof.dr. P. Reiss, co-promotor: dr. M.A.
van Agtmael
2
2 juli 2009
Abel Thijs
Platelet activity and atherothrombosis
Promotoren: prof.dr P.C. Huijgens en prof.dr C.D.A. Stehouwer
3
18 september 2009:
Geeske Peeters (EMGO)
Preventie van val-ongevallen bij ouderen met een hoog valrisico.
Promotoren: prof. dr. P. Lips, prof. dr. L.M. Bouter, copromotoren: dr.
P.J.M. Elders, dr. N.M. van Schoor
4
27 november 2009
Mike Peters
The link between cardiovascular and rheumatic disease: More than a
coincidence?
Promotoren: prof.dr B.A.C. Dijkmans en prof.dr Y.M. Smulders
Co-promotoren: dr. M.T. Nurmohamed en dr. I.E. van der Horst-Bruinsma
17